EyePoint, Inc. (EYPT)
3.25
+0.02
(+0.62%)
USD |
NASDAQ |
Oct 02, 16:00
3.25
0.00 (0.00%)
After-Hours: 20:00
EyePoint Net Income (Quarterly) : -94.47M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -94.47M |
| March 31, 2026 | -84.83M |
| December 31, 2025 | -67.61M |
| September 30, 2025 | -59.73M |
| June 30, 2025 | -59.43M |
| March 31, 2025 | -45.20M |
| December 31, 2024 | -41.40M |
| September 30, 2024 | -29.36M |
| June 30, 2024 | -30.83M |
| March 31, 2024 | -29.28M |
| December 31, 2023 | -14.10M |
| September 30, 2023 | -12.61M |
| June 30, 2023 | -22.92M |
| March 31, 2023 | -21.16M |
| December 31, 2022 | -43.45M |
| September 30, 2022 | -18.42M |
| June 30, 2022 | -19.41M |
| March 31, 2022 | -20.98M |
| December 31, 2021 | -19.43M |
| September 30, 2021 | -16.70M |
| June 30, 2021 | -10.01M |
| March 31, 2021 | -12.28M |
| December 31, 2020 | -15.47M |
| September 30, 2020 | -3.801M |
| June 30, 2020 | -12.95M |
| Date | Value |
|---|---|
| March 31, 2020 | -13.17M |
| December 31, 2019 | -10.41M |
| September 30, 2019 | -15.65M |
| June 30, 2019 | -11.50M |
| March 31, 2019 | -19.24M |
| December 31, 2018 | -11.59M |
| September 30, 2018 | -33.13M |
| June 30, 2018 | -34.43M |
| March 31, 2018 | -6.978M |
| June 30, 2017 | -6.116M |
| March 31, 2017 | -5.14M |
| December 31, 2016 | -0.067M |
| September 30, 2016 | -7.162M |
| June 30, 2016 | -6.387M |
| March 31, 2016 | -5.041M |
| December 31, 2015 | -5.186M |
| September 30, 2015 | -4.933M |
| June 30, 2015 | -5.146M |
| March 31, 2015 | -4.998M |
| December 31, 2014 | -4.075M |
| September 30, 2014 | 20.57M |
| June 30, 2014 | -3.967M |
| March 31, 2014 | -2.187M |
| December 31, 2013 | -3.514M |
| September 30, 2013 | -3.687M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -78.76M |
| Eli Lilly & Co. | 7.095B |
| Elanco Animal Health, Inc. | 54.00M |
| Amylyx Pharmaceuticals, Inc. | -43.42M |
| Nuvation Bio, Inc. | -62.84M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.507M |
| Total Expenses (Quarterly) | 94.98M |
| EPS Diluted (Quarterly) | -1.092 |
| Enterprise Value | 118.09M |
| Gross Profit Margin (Quarterly) | -36.09% |
| Profit Margin (Quarterly) | -18.63K% |
| Earnings Yield | -115.2% |
| Normalized Earnings Yield | -115.19 |